Cargando…

Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients

BACKGROUND: Neutralizing antibodies are important for protection against the pandemic SARS-CoV-2 virus, and long-term memory responses determine the risk of re-infection or boosting after vaccination. T-cellular responses are considered important for partial protection against novel variants of conc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohn, Kristin G.-I., Bredholt, Geir, Zhou, Fan, Madsen, Anders, Onyango, Therese B., Fjelltveit, Elisabeth B., Jalloh, Sarah L., Brokstad, Karl A., Cantoni, Diego, Mayora-Neto, Martin, Temperton, Nigel, Langeland, Nina, Cox, Rebecca J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863217/ https://www.ncbi.nlm.nih.gov/pubmed/35192617 http://dx.doi.org/10.1371/journal.pone.0261979

Ejemplares similares

Durable immune responses after BNT162b2 vaccination in home-dwelling old adults
por: Hansen, Lena, et al.
Publicado: (2023)

SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients
por: Onyango, Therese Bredholt, et al.
Publicado: (2023)

Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study
por: Fjelltveit, Elisabeth B, et al.
Publicado: (2022)

SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity
por: Mohn, Kristin G-I, et al.
Publicado: (2023)

The role of pseudotype neutralization assays in understanding SARS CoV-2
por: Cantoni, Diego, et al.
Publicado: (2021)

Point-of-Care Influenza Testing Impacts Clinical Decision, Patient Flow, and Length of Stay in Hospitalized Adults( )
por: Fjelltveit, Elisabeth B, et al.
Publicado: (2020)

Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers
por: Bansal, Amit, et al.
Publicado: (2023)

Long COVID in a prospective cohort of home-isolated patients
por: Blomberg, Bjørn, et al.
Publicado: (2021)

Longevity of B-Cell and T-Cell Responses After Live Attenuated Influenza Vaccination in Children
por: Mohn, Kristin G.-I., et al.
Publicado: (2015)

SARS-CoV-2–Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study
por: Trieu, Mai-Chi, et al.
Publicado: (2020)

Post COVID-19 condition after delta infection and omicron reinfection in children and adolescents
por: Ertesvåg, Nina Urke, et al.
Publicado: (2023)

Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study
por: Kuwelker, Kanika, et al.
Publicado: (2021)

Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils
por: Mohn, Kristin Greve-Isdahl, et al.
Publicado: (2016)

Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms
por: Cantoni, Diego, et al.
Publicado: (2022)

Seroconversion in household members of COVID-19 outpatients
por: Cox, Rebecca J, et al.
Publicado: (2021)

A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern
por: Ertesvåg, Nina Urke, et al.
Publicado: (2022)

Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature
por: Cantoni, Diego, et al.
Publicado: (2023)

Capture and inactivation of viral particles from bioaerosols by electrostatic precipitation
por: Preston, Hannah E., et al.
Publicado: (2023)

Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post–COVID-19 Convalescent Samples
por: Shrwani, Khalid, et al.
Publicado: (2021)

Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination
por: Mohn, Kristin G. I., et al.
Publicado: (2017)

Seasonal influenza vaccination expands hemagglutinin-specific antibody breadth to older and future A/H3N2 viruses
por: Ertesvåg, Nina Urke, et al.
Publicado: (2022)

Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
por: Horvath, Dennis, et al.
Publicado: (2023)

Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses
por: Sampson, Alexander Thomas, et al.
Publicado: (2021)

The expression of B & T cell activation markers in children's tonsils following live attenuated influenza vaccine
por: Panapasa, Jack A, et al.
Publicado: (2015)

Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients
por: Cantoni, Diego, et al.
Publicado: (2022)

Durability of the humoral immune response in recovered COVID-19 patients
por: Mahallawi, Waleed, et al.
Publicado: (2021)

Human seasonal coronavirus neutralization and COVID‐19 severity
por: Wells, David A., et al.
Publicado: (2022)

Instructing durable humoral immunity for COVID-19 and other vaccinable diseases
por: Bhattacharya, Deepta
Publicado: (2022)

Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets
por: Cox, Rebecca J., et al.
Publicado: (2015)

The production and development of H7 Influenza virus pseudotypes for the study of humoral responses against avian viruses
por: Molesti, Eleonora, et al.
Publicado: (2013)

Complement Activation-Independent Attenuation of SARS-CoV-2 Infection by C1q and C4b-Binding Protein
por: Beirag, Nazar, et al.
Publicado: (2023)

Different decay of antibody response and VOC sensitivity in naïve and previously infected subjects at 15 weeks following vaccination with BNT162b2
por: Siracusano, Gabriel, et al.
Publicado: (2022)

Actinomycetes from Sediments in the Trondheim Fjord, Norway: Diversity and Biological Activity
por: Bredholt, Harald, et al.
Publicado: (2008)

Humoral immunity for durable control of SARS-CoV-2 and its variants
por: Kotaki, Ryutaro, et al.
Publicado: (2023)

Live-Attenuated Influenza Vaccine Induces Tonsillar Follicular T Helper Cell Responses That Correlate With Antibody Induction
por: Lartey, Sarah, et al.
Publicado: (2020)

A Comparison of p53 Isoform Profiles and Apoptosis Induced by Camptothecin or a Herbal Khat Extract (Catha Edulis (Vahl) Forssk. ex Endl.) in Leukemic Cell Lines: Exploring Cellular Responses in Therapy Development
por: Onyango, Therese Bredholt, et al.
Publicado: (2020)

Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment
por: Ertesvåg, Nina Urke, et al.
Publicado: (2022)

Post epidemic giardiasis and gastrointestinal symptoms among preschool children in Bergen, Norway. A cross-sectional study
por: Mellingen, Kristin M, et al.
Publicado: (2010)

Durability of AZD1222 and hybrid humoral immunity against omicron BA.1 and BA.4
por: Soto-Rifo, Ricardo
Publicado: (2023)

Population-based study of the durability of humoral immunity after SARS-CoV-2 infection
por: Peterhoff, David, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bea9pr8r21shrijlst61ptgnsi